TGFB1 and non-small cell lung carcinoma: We have previously performed a metabolome analysis of three TGF‐β‐treated NSCLC cell lines and identified the alteration of pyrimidine metabolism (e.g. CTP/UTP metabolism) across all cell lines [18].